Suppression of Cell Growth, Migration and Drug Resistance by Ethanolic Extract of Antrodia cinnamomea in Human Lung Cancer A549 Cells and C57BL/6J Allograft Tumor Model

ASIAIR > College of Medical and Health Science > Department of Post-Baccalaureate Veterinary Medicine > journal paper > Item 310904400/111533

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/111533

Title:	Suppression of Cell Growth, Migration and Drug Resistance by Ethanolic Extract of Antrodia cinnamomea in Human Lung Cancer A549 Cells and C57BL/6J Allograft Tumor Model
Authors:	Wu, Chi-Han;Wu, Chi-Han;Liu, Fon-Cha;Liu, Fon-Chang;Pan, Chun-Hs;Pan, Chun-Hsu;Lai, Ming-Ts;Lai, Ming-Tsung;藍守仁;Wu, Chieh-Hs;Wu, Chieh-Hsi;Sheu, Ming-J;Sheu, Ming-Jyh;*
Contributors:	學士後獸醫學系
Date:	2018-03
Issue Date:	2018-10-22
Abstract:	The purpose of this study was to investigate the inhibitory activities of ethanolic extracts from Antrodia cinnamomea (EEAC) on lung cancer. Cell proliferation and cell cycle distribution were analyzed using (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay and flow cytometry, respectively. Wound-healing assay, Western blotting, and a murine tumor model were separately used to examine cell migration, protein expression, and tumor repression. Our results showed that EEAC induced cell cycle arrest at the G0/G1 phase resulting decreased cell viability in A549 cells. Moreover, EEAC up-regulated the growth-suppressing proteins, adenosine 5′-monophosphate-activated protein kinase (AMPK), p21 and p27, but down-regulated the growth-promoting proteins, protein kinase B (Akt), mammalian tarfet of rapamycin (mTOR), extracellular signal-regulating kinase 1/2 (ERK1/2), retinoblastoma protein (Rb), cyclin E, and cyclin D1. EEAC also inhibited A549 cell migration and reduced expression of gelatinases. In addition, our data showed that tumor growth was suppressed after treatment with EEAC in a murine allograft tumor model. Some bioactive compounds from EEAC, such as cordycepin and zhankuic acid A, were demonstrated to reduce the protein expressions of matrix metalloproteinase (MMP)-9 and cyclin D1 in A549 cells. Furthermore, EEAC enhanced chemosensitivity of A549 to paclitaxel by reducing the protein levels of caveolin-1. Our data suggests that EEAC has the potential to be an adjuvant medicine for the treatment of lung cancer. (PDF) Suppression of Cell Growth, Migration and Drug Resistance by Ethanolic Extract of Antrodia cinnamomea in Human Lung Cancer A549 Cells and C57BL/6J Allograft Tumor Model. Available from: https://www.researchgate.net/publication/323668354_Suppression_of_Cell_Growth_Migration_and_Drug_Resistance_by_Ethanolic_Extract_of_Antrodia_cinnamomea_in_Human_Lung_Cancer_A549_Cells_and_C57BL6J_Allograft_Tumor_Model [accessed Oct 22 2018].
Relation:	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Appears in Collections:	[Department of Post-Baccalaureate Veterinary Medicine] journal paper

Files in This Item:

File	Size	Format
index.html	0Kb	HTML	450	View/Open

Loading...